Behere, Rishikesh V et al
Ruggeri RM, Barbalace MC, Croce L, Malaguti M, Campenn A, Rotondi M et al (2023) Autoimmune Thyroid Disorders: The Mediterranean Diet as a Protective Choice
cerevisiae BY4741 to replace the GSH1 promoter with the strong constitutive promoter pTEF1 by homologous recombination, with pgsh1 D:: HIS3MX6-pTEF1 transformants selected by growth in YNB minus histidine
Yes, combining glycine with NAC has been shown to more effectively boost glutathione levels and support mitochondrial function compared to NAC alone
A dedicated phase 3 programRENEWwas announced in late 2025 to investigate cagrilintide monotherapy specifically
Its evidence base is genuinely strong for a trial-stage product two large Phase 3a randomized controlled trials plus a Phase 1b pharmacology study but it has not received marketing approval from any regulator, and its complete benefitrisk profile is still being evaluated